At Astellas, we are committed to turning innovative science into VALUE for patients. Changing tomorrow is the ethos that guides everything we do – and is the measure by which we judge our success.
Throughout my life I have had a passion for healthcare and am driven by helping to address the unmet needs of patients around the world. Working with a company that is so active in research and able to act with agility to ‘follow the science’ and respond to changes in the healthcare environment is what motivates and inspires me every day.
“At a time when healthcare systems across the world are stretched and the needs of patients are constantly evolving, we must demonstrate that our science and medicines can have a real and measurable impact”
This means putting the patient at the heart of every decision we make, delivering treatments of value that directly improve and save patients’ lives, focusing on where the need is great, but treatment options are few – pioneering at pace to discover medicines with the possibility of making a difference in the lives of patients, often in under-served areas or rare conditions.
We have a great culture of teamwork that has grown from our Japanese roots. It also allows us to have a collaborative and open company culture where we invite everyone to participate and contribute to how we work together. Our employees are passionate about their work and are the driving force behind our dynamic organisation.
Our ethos is underpinned by the Astellas Way, represented by five core values – patient focus, openness, integrity, ownership and results. Our aspiration is to bring the best brains together, then provide them with world-leading tools, resources and a unique structure that fosters real agility, collaboration and a true challenger spirit.
In the wider sense, being an agile, science-led and patient-first organisation makes us good partners for experts in their respective fields, working side-by-side with those who share our vision and dedication to deliver value through healthcare solutions that have the potential to improve health and redefine care.
President, Established Markets, Astellas Pharma Europe
NON_2021_0092_UK. June 2021